Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Eur J Clin Pharmacol. 2009 Aug 11;65(9):947–953. doi: 10.1007/s00228-009-0707-7

Table 3.

Changes in Clinical Parameters by Renal Disease from Baseline to Follow-up

Primary Renal Disease
WT
(n = 29)
Variant
(n = 7)
P value
Δ SBP (mm Hg) −3.6 (26.3) −1.7 (14.2) 0.863
Δ DBP (mm Hg) −0.2 (13.8) −1.2 (13.8) 0.879
Δ SCr (mg/dL) 0.2 (0.6) 0.2 (0.8) 0.606
Δ eGFR (mL/min/1.73m2) 6.5 (13.6) 8.5 (14.5) 0.734
Δ UP (mg/day) −1278 (4277) −458 (1651) 0.139
Δ % UP −125 (323) −31.7 (156) 0.123
Δ Dose (mg) 9.8 (22.9) 0 (47.4) 0.540
Secondary Renal Disease
WT
(n = 18)
Variant
(n = 5)
P value
Δ SBP (mm Hg) −5.5 (17.5) 16.2 (27.1) 0.044
Δ DBP (mm Hg) −3.2 (10.6) 9.8 (16.0) 0.043
Δ SCr (mg/dL) −0.02 (0.5) −0.3 (0.9) 0.530
Δ eGFR (mL/min/1.73m2) 2.7 (8.7) 5.2 (11.6) 0.493
Δ UP (mg/day) −1161 (2192) −5.7 (210) 0.611
Δ %UP −67.3 (121) 1.4 (106) 0.521
Δ Dose (mg) 15.3 (24.5) 20.0 (27.4) 0.793

Data are presented as mean (standard deviation)

DBP – diastolic blood pressure; eGFR – estimated glomerular filtration rate via Modification of Diet in Renal Disease equation [14], SBP – systolic blood pressure; SCr – serum creatinine, UP – urinary protein to creatinine ratio, WT = wild type Variant = presence of a *2 and/or *3 allele